AU2003247252A1 - Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases - Google Patents

Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases

Info

Publication number
AU2003247252A1
AU2003247252A1 AU2003247252A AU2003247252A AU2003247252A1 AU 2003247252 A1 AU2003247252 A1 AU 2003247252A1 AU 2003247252 A AU2003247252 A AU 2003247252A AU 2003247252 A AU2003247252 A AU 2003247252A AU 2003247252 A1 AU2003247252 A1 AU 2003247252A1
Authority
AU
Australia
Prior art keywords
diagnosis
human
neurodegenerative diseases
diagnostic use
pharmaceutical substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003247252A
Inventor
Vladimir Agueev
Michael Wilhelm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MERDIQUANT GmbH
Original Assignee
MERDIQUANT GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MERDIQUANT GmbH filed Critical MERDIQUANT GmbH
Publication of AU2003247252A1 publication Critical patent/AU2003247252A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
AU2003247252A 2002-07-04 2003-07-03 Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases Abandoned AU2003247252A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10230838.1 2002-07-04
DE2002130838 DE10230838B4 (en) 2002-07-04 2002-07-04 Diagnostic use of pharmaceutical substances
PCT/DE2003/002288 WO2004005930A2 (en) 2002-07-04 2003-07-03 Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases

Publications (1)

Publication Number Publication Date
AU2003247252A1 true AU2003247252A1 (en) 2004-01-23

Family

ID=29761777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003247252A Abandoned AU2003247252A1 (en) 2002-07-04 2003-07-03 Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases

Country Status (3)

Country Link
AU (1) AU2003247252A1 (en)
DE (1) DE10230838B4 (en)
WO (1) WO2004005930A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172604B (en) * 2011-12-22 2015-06-24 北大方正集团有限公司 Lovastatin purification method combining auxiliary magnetic crystallization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086165A1 (en) * 1992-04-09 1993-10-10 Paul P. Tamburini Diagnostic assay for alzheimer's disease based on the proteolysis of alzheimer's precursor protein
GB9908059D0 (en) * 1999-04-09 1999-06-02 Imp College Innovations Ltd Diagnosis and treatment of diseases
US6589504B1 (en) * 2000-09-22 2003-07-08 Pharmacia & Upjohn Company Compounds and methods for diagnosing and treating amyloid-related conditions
DE10130727C2 (en) * 2001-06-21 2003-09-18 Mediquant Gmbh Method and device for measuring micro-viscosity changes as an immunoassay

Also Published As

Publication number Publication date
DE10230838B4 (en) 2005-02-03
DE10230838A9 (en) 2004-09-09
WO2004005930A3 (en) 2004-03-18
WO2004005930A2 (en) 2004-01-15
DE10230838A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003239531A1 (en) Protein cages for the delivery of medical imaging and therapy
AU2003295644A1 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
HK1114419A1 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
AU2003261073A1 (en) Combined diagnostic and therapeutic ultrasound system
EP1571970A3 (en) Diagnosis and monitoring of diseases
AU2003219689A1 (en) Method and system for risk-modulated diagnosis of disease
EP1578421A4 (en) Pharmaceutical preparations for treatments of diseases and disorders of the breast
EP1627410A4 (en) Computed tomography system for imaging of human and small animal
AU2003246102A1 (en) Method of examining allergic disease and drug for treating the same
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
AU2003223172A1 (en) Use of the axl receptor for diagnosis and treatment of renal disease
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2003904328A0 (en) Diagnosis and treatment of neurodegenerative disorders
EP1532162A4 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
AU2003246592A1 (en) Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2003246380A1 (en) Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases
AU2003278497A1 (en) Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases
AU2003260301A1 (en) Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
AU2003223033A1 (en) System for point of care diagnosis and/or analysis
AU2003279312A1 (en) Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases
AU2002352054A1 (en) "in vitro" diagnostic method for diseases affecting human or animal tissues
AU2003247252A1 (en) Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases
AU2003245858A1 (en) Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases
AU2003242588A1 (en) Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase